1. Home
  2. ACOG vs INTT Comparison

ACOG vs INTT Comparison

Compare ACOG & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • INTT
  • Stock Information
  • Founded
  • ACOG 2000
  • INTT 1981
  • Country
  • ACOG Canada
  • INTT United States
  • Employees
  • ACOG N/A
  • INTT N/A
  • Industry
  • ACOG
  • INTT Semiconductors
  • Sector
  • ACOG
  • INTT Technology
  • Exchange
  • ACOG Nasdaq
  • INTT Nasdaq
  • Market Cap
  • ACOG 80.3M
  • INTT 77.3M
  • IPO Year
  • ACOG N/A
  • INTT 1997
  • Fundamental
  • Price
  • ACOG $10.80
  • INTT $7.53
  • Analyst Decision
  • ACOG Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • ACOG 1
  • INTT 2
  • Target Price
  • ACOG $20.00
  • INTT $12.00
  • AVG Volume (30 Days)
  • ACOG 67.2K
  • INTT 29.7K
  • Earning Date
  • ACOG 08-14-2025
  • INTT 08-01-2025
  • Dividend Yield
  • ACOG N/A
  • INTT N/A
  • EPS Growth
  • ACOG N/A
  • INTT N/A
  • EPS
  • ACOG N/A
  • INTT N/A
  • Revenue
  • ACOG $2,928,654.00
  • INTT $127,503,000.00
  • Revenue This Year
  • ACOG N/A
  • INTT N/A
  • Revenue Next Year
  • ACOG N/A
  • INTT $10.07
  • P/E Ratio
  • ACOG N/A
  • INTT N/A
  • Revenue Growth
  • ACOG N/A
  • INTT 5.19
  • 52 Week Low
  • ACOG $3.75
  • INTT $5.24
  • 52 Week High
  • ACOG $11.54
  • INTT $11.92
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • INTT 58.40
  • Support Level
  • ACOG N/A
  • INTT $7.01
  • Resistance Level
  • ACOG N/A
  • INTT $8.14
  • Average True Range (ATR)
  • ACOG 0.00
  • INTT 0.45
  • MACD
  • ACOG 0.00
  • INTT 0.02
  • Stochastic Oscillator
  • ACOG 0.00
  • INTT 63.38

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: